# GTG Capital Partners

> GTG Capital Partners is a VC fund in San Francisco backing Medical and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: San Francisco, United States
- Total investments: 1
- Last investment: Oct 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/gtg-capital-partners-pty-ltd
- Website: http://www.gtgcapital.com.au

GTG Capital Partners is a private equity fund that makes $10-100 million active investments in select, under-appreciated middle-market technology companies that it believes can be pivoted into technological and market disruptions for high growth. GTG actively works with their companies to engineer this hypergrowth by deploying proven bestpractices and proprietary management techniques.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Wellmarker Bio | Their Company has developed a biomarker-based cancer drugs based on accumulated developmental experience and know-how. They have a new drug development institute including synthetic and bio-research and management support center.Utilizing R&D infrastructure from Asan Medical Center in Seoul Republic of Korea they are focusing on developingnew drugs that overcome resistance of existing therapeutic approaches.Additionally they are focusing on developing first-in-class biomarker-based drugs for medical unmet needs in various cancers such as colon cancer, lung cancer and liver cancer. | $11.8M | Series C | Oct 14, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Cytogen](https://shizune.co/investors/profile/cytogen) — VC Fund, 1 deal together
- [eBEST](https://shizune.co/investors/profile/ebest-33b0) — VC Fund, 1 deal together
- [Elohim Partners](https://shizune.co/investors/profile/elohim-partners) — VC Fund, 1 deal together
- Jin & Investment Partners — VC Fund, 1 deal together
- Lead Compass Investment — VC Fund, 1 deal together
- [Magellan Technology Investment](https://shizune.co/investors/profile/magellan-technology-investment) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does GTG Capital Partners invest in?

GTG Capital Partners invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did GTG Capital Partners last invest?

The most recent investment recorded for GTG Capital Partners closed in Oct 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co